A randomized prospective study of intravesical prophylaxis in non-musle invasive bladder cancer at intermediate risk of recurrence: mitomycin chemotherapy vs BCG immunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/19235434

Download in:

View as

General Info

PMID
19235434